Pelareorep is also showing strong results in anal cancer, where third-line patients achieved a 29% response rate with responses lasting around 17 months in a setting with no FDA-approved treatments.

House Speaker Mike Johnson faces tough days ahead trying to muscle a federal funding package to passage and prevent a ...

Republican leadership in the House is hoping to begin the process of reopening the government by advancing a funding package ...

Invesco Large Cap Growth ETF has 50 stocks, a 27.8x P/E, mid-cap exposure, and sector leads in tech, staples, and financials.

Q4 2025 Earnings Call February 2, 2026 5:00 PM ESTCompany ParticipantsAna Soro - Office of the CFORyan Taylor - ...

March S&P 500 E-Mini futures (ESH26) are down -0.57%, andMarch Nasdaq 100 E-Mini futures (NQH26) are down -0.92% this morning, pointing to a lower open on Wall Street as investors continue to sell ...

The company reported a strong holiday quarter on Thursday. But its spending, like that at other big technology companies, is ...

The company boosted its 2026 capital expenditures to $200 billion, with most of the spending going to data centers.

Growth is fueled by rising adoption of wearable healthcare devices, advanced patient monitoring systems, and AI-driven ...

Feb 1 (Reuters) - Oracle expects ​to raise $45 billion to $50 billion in 2026 to build additional capacity ‍for its cloud ...

Growth is fueled by rising demand for advanced diagnostic systems, home-based monitoring solutions, and robotic-assisted surgical devices, alongside surging chronic disease prevalence and an aging ...

The government's 10-year plan includes an expansion of robot-assisted surgery and faster diagnostic tests to reduce delays in cancer diagnosis and treatment.